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BY-NC-ND license (http://creativecomAbstract Background: The active metabolite (1, 25-dihydroxycholecalciferol) of vitamin D
(25-hydroxycholecalciferol) leads to the activation of macrophages and the deficiency of
vitamin D seems to be involved in the risk of tuberculosis (TB). The effects of vitamin D are
exerted by interaction with the vitamin D receptor (VDR) and vitamin D receptor binding pro-
tein (VDBP) may be influenced by polymorphisms in the VDR and VDBP genes. In this study, vari-
ation in the VDR and VDBP genes was investigated in a Taiwanese population with TB.
Methods: We typed four VDR polymorphisms of restriction endonuclease sites for ApaI, TaqI,
BsmI, and FokI and three VDBP polymorphismsdThr420Lys, Asp416Glu, and Cys299Cysdin
198 patients with TB and 170 healthy volunteers.
Results: VDR TaqI, VDR BsmI, and VDBP Asp416Glu were significantly associated with TB sus-
ceptibility. Odd ratios of risk genotypes of the above three polymorphisms were 2.16 (95% con-
fidence interval 1.01, 4.65), 2.14 (95% confidence interval 1.06, 4.31), and 2.24 (95%
confidence interval 1.04, 4.80), respectively. VDBP haplotype analysis showed Gc1f carriers
associated to TB.
Conclusion: The polymorphisms in the VDR and VDBP genes appeared to be responsible for host
susceptibility to human TB in a Taiwanese population.
Copyright ª 2016, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Medical Sciences, Tzu Chi University, 701 Zhongyang Road, Section 3, Hualien, 97004, Taiwan.
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According to the World Health Organization (WHO),
approximately 8.6 million cases (8.3e9.0 million) of
tuberculosis (TB) were estimated to have occurred in
2012, of which approximately 2.9 million were female.
Most cases are estimated to have occurred in Asia and
Africa (58% and 27%, respectively), with the highest inci-
dence in India (2.0e2.4 million) and China (0.9e1.1
million), together accounting for 38% of the total number
of cases.1 Previous studies in Taiwan have demonstrated a
five-fold higher incidence of TB among aborigines as
compared to Han Chinese.2 In addition, polymorphisms of
the NRAMP1 gene appear to be associated with suscepti-
bility to TB among aborigines, but not among the Han
Chinese population.2 Our previous study showed poly-
morphisms in the interferon-g gene to be associated with
TB in the Han Taiwanese population.3 The genetic sus-
ceptibility to TB in Han Chinese living in Taiwan is remains
unknown.
Calcitriol, (also known as 1, 25-dihydroxyvitamin D3 and
1, 25(OH)2D3), an immunomodulatory hormone, acts via the
vitamin D receptor (VDR) to alter genomic signaling.4 It
regulates the differentiation and growth of various immune
cells and the derivatives of calcitriol have been shown to
inhibit the functional differentiation of dendritic cells,
cytotoxic T-cells, and helper T-cells.5,6 Calcitriol inhibits
the Th1 cytokine production and augments production of T-
cell suppressing cytokines, TGF-b1 and IL-4.7 Studies have
shown that calcitriol inhibits NK cell activity and differen-
tiation of lymphokine-activated killer cells.8 It suppresses
the growth of Mycobacterium tuberculosis in mononuclear
phagocytes9 and toll-like receptor activation of human
macrophages has been shown to upregulate expression of
VDR and vitamin D 1a-hydroxylase genes leading to induc-
tion of cathelicidin and killing of M. tuberculosis.10,11 VDR
gene variants have a wide role in innate immunity and
specifically in TB and are associated with TB.12e16 The most
well-known polymorphisms in the 30 untranslated region
(UTR) and start codon of VDR gene are ApaI, BsmI, TaqI, and
FokI, respectively. Some studies have indicated a strong
association between BsmI gene polymorphism and pulmo-
nary TB.12,17 It was seen that the f/f genotype for FokI and
t/t genotype for TaqI occurred more frequently in TB
patients.15,18
Vitamin D metabolites in the circulation are bound to
vitamin D binding protein (DBP), a widely expressed
multifunctional 58 kDa serum glycoprotein encoded on
chromosome 4. The DBP locus is among the most poly-
morphic known.19 Two common polymorphisms at codons
416 (GAT/GAG, Asp/Glu) and 420 (ACG/AAG,
Thr/Lys) of exon 11 of the DBP gene (defined by the
presence of restriction endonuclease sites for HaeIII and
StyI, respectively) give rise to the three major electro-
phoretic variants of DBP, termed group-specific compo-
nent 1 fast (Gc1F), Gc1 slow (Gc1S), and Gc2. These
variants differ in their functional characteristics: the Gc1F
and Gc1S variants have been reported to have a greater
affinity for 25 (OH)D than the Gc2 variant,20 potentially
leading to more efficient delivery of 25(OH)D to the target
tissues, while the Gc2 variant is associated with decreasedcirculating concentrations of 25(OH)D, 1,25(OH)2D and
DBP.21,22 The Gc2/2 genotype of VDRP was strongly asso-
ciated with susceptibility to active tuberculosis in Gujarati
Asians, compared with Gc1/1 genotype.23
In this study, we examined the polymorphisms of VDR
and VDBP to gain a better understanding about the possible
correlation between genetic risk factors and susceptibility
to TB in Taiwanese patients.
Materials and methods
Participants
A total of 198 patients who were treated for active TB at
the General Taoyuan Hospital (Taoyuan, Taiwan) between
2009 and 2011 were surveyed consecutively. The inclusion
criteria were: adult patients newly diagnosed with active
TB, having evident lesions of TB by simple X-ray, computed
tomography, and positive results of sputum smears and
cultures for mycobacteria. In the control group, 170 vol-
unteers without active TB or a history of TB were enrolled.
Individuals with latent TB (confirmed by physician and
Quantiferon test) history were excluded.
Written informed consent was obtained from each pa-
tient and volunteer enrolled in this study. The study pro-
tocol conformed to the ethical guidelines of the 1975
Declaration of Helsinki and was approved by the Ethics
Committee of Taoyuan General Hospital.
DNA preparation
Genomic DNA was extracted from oral swabs collected from
the 198 TB patients and 170 non-TB volunteers using a
QIAamp DNA Mini Kit (QIAGEN, Valencia, CA, USA) according
to the manufacturer’s instructions. The extracted genomic
DNA was analyzed using agarose gel electrophoresis and
quantitatively determined by spectrophotometry, and
stored at 80oC until use.
Single nucleotide polymorphism genotyping
All single nucleotide polymorphism (SNP) genotyping was
performed using TaqMan SNP genotyping assays (ABI:
Applied Biosystems Inc., Foster City, CA, USA). The primers
and probes of the selected SNPs were from an ABI assay on
demand kit. Reactions were carried out according to the
manufacturer’s protocol (TaqMan SNP Genotyping Assays,
protocol, Part Number 4332856 Rev. C). The probe fluo-
rescence signal detection was performed using an ABI Prism
7900 Real-Time PCR System.
Statistical analysis
The quality of the genotype data were evaluated by Har-
dyeWeinberg equilibrium proportion tests. The association
analyses were tested by the c2 test. Odds ratios and 95%
confidence intervals were calculated from contingency ta-
bles. SNP(s) showing significant association (p  0.05) in the
tests were further evaluated using logistic regressions
adjusted for age and sex in odds ratio analysis. All
Table 2 Genotyping frequencies of selected single
nucleotide polymorphisms (SNPs) of VDR and VDBP in the
tuberculosis (TB) and non-TB groups and results of the c2
test.
Polymorphism SNP ID allele Non-TB TB p
1/2* 11/12/22** 11/12/22**
VDR
ApaI rs7975232 A/C 16/65/89 17/78/103 0.950
TaqI rs731236 A/G 149/20/1 186/12/0 0.083
BsmI rs1544410 A/G 0/24/146 1/14/183 0.058
FokI rs2228570 A/G 32/87/51 50/104/44 0.144
VDBP
Thr420Lys rs4588 A/C 15/62/93 14/80/104 0.669
Asp416Glu rs7041 A/C 80/69/21 102/84/12 0.106
Cys299Cys rs4725 C/T 1/22/147 4/24/170 0.488
*1: allele 1, 2: allele 2; **11: homozygous of allele 1, 12: het-
erozygous, 22: homozygous of allele 2.
Table 3 Odds ratio analysis of selected single nucleotide
polymorphisms (SNPs).
SNP ID Genotype Non-TB TB p OR (95% CI)*
rs7975232
(ApaI)
AAþAC
CC
81
89
89
103
0.949 n.d.
rs731236
(TaqI)
AA
AGþGG
(ref.)
149
21
186
12
0.035 2.16
(1.01, 4.65)
p Z 0.048
rs1544410
(BsmI)
AAþAG
(ref.)
GG
24
146
15
183
0.042 2.14
(1.06, 4.31)
p Z 0.034
rs2228570
(FokI)
AAþAG
GG
119
51
154
44
0.089 n.d.
rs4588
(Thr420Lys)
AAþAC
CC
77
93
94
104
0.676 n.d.
rs7041
(Asp416Glu)
AAþAC
CC (ref.)
149
21
186
12
0.035 2.24
(1.04, 4.80)
p Z 0.039
rs4725
(Cys299Cys)
CCþCT
TT
23
147
28
170
0.865 n.d.
* Adjusted for sex and age by logistic regression.
CI Z confidence interval; n.d. Z not determined; OR Z odds
ratio; ref. Z reference genotype.
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(SPSS Inc., Chicago, IL, USA).
Results
Demographic information of the study participants
In this study, 198 patients diagnosed with TB and 170 control
individuals without history of TB infection were enrolled.
There were significant differences in sex and age between
groups. Male sex was more prevalent in the case group
(Table 1). The average ages of the case and control group
were found to have no significant differences (Table 1).
VDR and VDBP variant(s) associated with
susceptibility to tuberculosis
Seven selected SNPs were genotyped by TaqMan SNP gen-
otyping assays. None of the genotype distributions of the
tested SNPs in the study participants deviated from the
HardyeWeinberg equilibrium. The strengths of associations
and genotype frequencies of all selected SNPs with TB are
summarized in Table 2. None of the SNPs appeared to be
significantly associated with TB.
The odds ratio analysis adjusted by sex and age showed
that AA of rs731236, GG of rs1544410 and A carriers
(AAþAC) of rs7041 were risk genotypes for susceptibility to
TB (Table 3).
The polymorphisms rs4588 and rs7041 of VDBP were
further analyzed according Gc2/Gc1 haplotype. The Gc1f
carriers were associated with susceptibility of TB (Table 4).
Discussion
In this study, we revealed the SNPs rs731236 (TaqI ) and
rs1544410 (BsmI ) of VDR and rs7041 (Asp416Glu) of VDBP
associated with susceptibility of TB in the Han Taiwanese
population. Genotypes AA of rs731236, GG of rs1544410 and
A carriers (AAþAC) of rs7041 were risk genotypes for sus-
ceptibility to TB.
The ApaI and BsmI polymorphisms were located in the
intron region between exon 8 and exon 9 of the VDR gene.
Although the nucleotide changes of the ApaI and BsmI
polymorphisms generated no changes in the amino acid or
the structure of the expressed VDR protein, they might be
in linkage disequilibrium with other functional poly-
morphisms which regulated VDR gene expression. EarlierTable 1 Demographic data of the study participants.
TB
(198 cases)
Non-TB
(170 controls)
p
Age (y),
mean  SD
55.78  10.99 55.76  18.62 0.199
Sex (n) Male: 137 Male: 79 < 0.001
Female: 61 Female: 91
Age was tested by t test; sex was tested by c2 test.
SD Z standard deviation TB Z tuberculosis.studies have provided evidence of differential luciferase
activity for the two 30 UTR variants that were linked to the
most frequent haplotypes.24 A previous meta-analysis
showed recessive model (aa) of the ApaI polymorphism
and dominant model (Bbþbb) for the BsmI polymorphism
both appeared to have a protective role on tuberculosis
development in the European population.25 Our result
showed homozygous of major allele of rs1544410 (BsmI: BB)
of VDR is a risk genotype for TB (Table 2), which is consis-
tent with the aforementioned meta-analysis in the Euro-
pean population.25 The ApaI polymorphism did not show
association to TB in our study population.
The mRNA coded from the TaqI t allele of the VDR gene
would be more stable than the mRNA from the T allele of
the VDR gene.26 Our result showed that rs731236 major
Table 4 VDRP polymorphisms rs4588/rs7041 genotype combinations and association to tuberculosis (TB).
rs4588/rs7041 AA/AA AC/AC* AC/AA CC/AA CC/AC CC/CC
Gc2/Gc2 Gc2/Gc1s Gc2/Gc1f Gc1f/Gc1f Gc1f/Gc1s Gc1s/Gc1s
Non-TB 15 29 33 32 40 21
TB 14 30 50 38 54 12
Non-Gc1f carriers** Gc1f carriers**
Non-TB 65 105 c2 Z 4.11
TB 56 142 p Z 0.0426
OR Z 1.57(95% CI: 1.014, 2.431)
* Frequency of the rs4588/rs7041 AC haplotype is extremely low due to linkage disequilibrium between loci; therefore individuals
heterozygous at both loci were assumed to carry AA/CC haplotypes: **: non-Gc1f carriers included Gc2/Gc2, Gc2/Gc1s and Gc1s/Gc1s,
Gc1f carriers included Gc2/Gc1f, Gc1f/Gc1f and Gc1f/Gc1s.
CI Z confidence interval; OR Z odds ratio.
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(Table 2). A previous study revealed that the TaqI SNP in
exon 9 near the 30 UTR was in linkage disequilibrium with
the ApaI and BsmI polymorphisms,27 which may explain the
same protective effect by the two variant alleles of the
TaqI and BsmI polymorphisms on tuberculosis.
The FokI SNP was located within the exon 2 of the VDR
gene, and evidence of FokI functionality has already been
obtained.28 Thus, the f allele of FokI might decrease the
activity of the VDR protein and deter the binding of active
vitamin D and VDR. Three meta-analyses on the FokI poly-
morphism were in accordance and indicated that the f
allele in a recessive model would increase the risk of
tuberculosis, and the same effect was found in the Chinese
population but not for other ethnicities.14,25,29 The associ-
ation between FokI and TB in our study population did not
show statistical significance, the marginal significant (Table
2; OR analysis, p Z 0.089), which may due to the small
sample size. The analysis of the effect of the FokI poly-
morphism on tuberculosis was underpowered.
In 1987 a possible correlation was proposed between the
homozygous Gc1F-phenotype and susceptibility to HIV
infection/severity of HIV-related disease. Gc2-2 by
contrast, should perform a protective role.30 Several later
studies refuted this statement.31e33 Gc2 homozygotes were
more common in TB relative to controls in two studies in
Asian populations,23,34 but the risk appears to depend on an
interaction between vitamin D status and genotype.36 In
Caucasian Russians, no GC genotype was associated with
TB.35 The association might be consistent with their
reduced ability to convert GC to macrophage-activating
factor, but requires further study as to the reasons for
synergy with vitamin levels. Our study was inconsistent with
previous studies and showed an association between Gc1F
carriers and risk of TB.
Previously, only one study had evaluated the DBP
phenotype in TB patients and no differences were seen
among patients and the control group.34 In that study, a 33%
frequency of Gc2 in TB patients was slightly but not
significantly higher than in the control group (26%), and this
elevation was at the expense of both Gc1F and Gc1S al-
leles.34 Further studies are necessary to understand the
physiological role of VDBP and its phenotypes on suscepti-
bility to TB and other diseases.
If the vitamin D axis plays a role in TB pathogenesis,36
variation within genes such as GC and VDR could berelevant in promoting resistance or susceptibility to the
infection. VDR has been more widely studied and genetic
variation within it appears to influence lymphocyte
response to M. tuberculosis.37 Nevertheless a meta-analysis
of VDR studies was inconclusive,38 perhaps due to small
study sizes and population heterogeneity. HIV status in
particular may influence the apparent effect of suscepti-
bility loci, perhaps because in HIV-positive individuals this
surpasses the small risk attributable to genetic factors.39
Therefore, further investigation, including functional and
genetic studies, for VDR and VDBP involving the pathology
of TB are necessary.Conflicts of interest
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